Skip to main content
. 2017 Feb 24;8(16):26505–26514. doi: 10.18632/oncotarget.15710

Figure 2. Cumulative incidence of AHDs according to the development of cGVHD.

Figure 2

The 3-year cumulative incidence of AHDs was 4.0 ± 1.3%, and the patients developed cGVHD had higher incidence than those who did't develope cGVHD (8.5 ± 3.7% vs 3.0 ± 1.3%, P = 0.021 ).